Document:

Exhibit 10.39

 Exhibit 10.39 
 EMPLOYMENT AGREEMENT 
 THIS EMPLOYMENT AGREEMENT
(the “Agreement”), dated as of December 19, 2011 (the “Effective Date”), is by and between IASIS Healthcare Corporation, a Delaware corporation (the “Company”), and Frank A. Coyle (the “Executive”).

 WHEREAS, the Executive is the Company’s General Counsel; 

WHEREAS, the Executive has experience beneficial to the Company’s operations, management and business development of
acute care hospitals, outpatient facilities and ancillary medical services (the “Business”); and 

WHEREAS, the parties desire to enter into this Agreement setting forth the terms and conditions of the employment
relationship of the Executive with the Company. 
 NOW, THEREFORE, intending to be legally bound hereby, the
parties agree as follows: 
 1. Employment. The Company hereby continues to employ the Executive and the
Executive hereby accepts continued employment with the Company, upon the terms and subject to the conditions set forth herein. 
 2. Term. 
 (a) Subject to termination pursuant to
Section 10 hereof, the term of the employment by the Company of the Executive pursuant to this Agreement (as the same may be extended, the “Term”) has commenced on the Effective Date and shall terminate on April 23, 2015.

 (b) Commencing on April 23, 2015 and on each subsequent anniversary thereof, the Term shall
automatically be extended for a period of one (1) additional year following the expiration of the otherwise applicable Term unless, not later than ninety (90) days prior to any such anniversary date, either party hereto shall have notified
the other party hereto in writing that such extension shall not take effect. 
 3. Position; Location.
During the Term, the Executive shall serve as General Counsel of the Company. The Executive shall perform such duties as the Chief Executive Officer or the Board shall determine, which duties shall not be materially inconsistent with the duties to
be performed by executives holding similar offices in similarly-sized healthcare corporations. The Executive shall report directly to the Chief Executive Officer. The parties acknowledge and agree that during the Term, (i) the Executive’s
principal office will not be moved to a location more than 20 miles from Metropolitan Nashville and Davidson County, Tennessee without his approval and (ii) the Company shall maintain, in the organizational documents thereof, indemnification
provisions providing for the maximum indemnification permitted by applicable law of the Executive by the Company for actions taken in his capacity as an officer or employee thereof (and, notwithstanding anything herein to the contrary, the
Executive’s right to indemnification shall survive termination of the Executive’s employment with the Company). 
 4. Duties. During the Term, the Executive shall devote all of his time and attention during normal business hours to the business and affairs of the Company. Notwithstanding the foregoing, with the
prior approval of the Chief Executive Officer, the Executive may serve as a director of other entities, provided, however that such entities do not directly compete with the Company in any material respect; and provided, further, that the Executive
may serve as a director of no more than one for profit entity at any time, and such service shall not interfere with his duties or responsibilities hereunder. 

  

 5. Salary and Bonus. 

(a) Commencing on the Effective Date and during the period in which the Executive serves as General Counsel, the Company
shall pay to the Executive a base salary at the rate of $390,000 per year. The Chief Executive Officer shall review the base salary annually and may increase such amount from time to time as it may deem advisable (such salary, as the same may be
increased, the “Base Salary”). The Base Salary shall be payable to the Executive in substantially equal installments in accordance with the Company’s normal payroll practices. 

(b) Commencing on the Effective Date and during the period in which the Executive continues to serve as General Counsel,
the Executive shall be eligible to receive for each fiscal year (or part thereof), an annual cash target bonus (the “Bonus”) of 50% of Base Salary (the “Bonus Target”), subject to the terms of the Company’s executive bonus
plan (the “Bonus Plan”) and subject to the satisfaction of certain performance objectives to be determined by the Chief Executive Officer or, to the extent more favorable to the Executive, other incentive compensation plan established by
the Board for the Company’s senior executive officers, as either of the same may be amended from time to time (provided that no such amendment or alternative plan shall diminish the Bonus Target). 

6. Stock Options. During the Term, the Executive shall be eligible to participate in the 2004 Stock Option Plan or
other equity plans established by the Board for the Company’s senior executive officers, as the same may be amended from time to time. 
 7. Vacation, Holidays and Sick Leave. During the Term, the Executive shall be entitled to paid vacation, paid holidays and sick leave in accordance with the Company’s standard policies for its
senior executive officers; provided that the Executive shall during each year of the Term be entitled to at least five (5) weeks of such vacation, which shall not accrue from year to year. 

8. Business Expenses. The Executive shall be reimbursed for all reasonable and necessary business expenses
incurred by him in connection with his employment (including, without limitation, expenses for travel and entertainment incurred in conducting or promoting business for the Company) upon timely submission by the Executive of receipts and other
documentation in accordance with the Company’s normal expense reimbursement policies. 
 9. Other
Benefits. During the Term, the Executive shall be eligible to participate fully in all health and other employee benefit arrangements available to senior executive officers of the Company generally. 

10. Termination of Agreement. The Executive’s employment by the Company pursuant to this Agreement shall not
be terminated prior to the end of the Term hereof except as set forth in this Section 10. 
 (a) By
Mutual Consent. The Executive’s employment pursuant to this Agreement may be terminated at any time by the mutual written agreement of the Company and the Executive. 

(b) Death. The Executive’s employment pursuant to this Agreement shall be terminated upon the death of the
Executive, in which event the Executive’s spouse or heirs shall receive (i) all Base Salary, vacation, annual bonus in respect of the immediately preceding year (to the extent not already paid), and entitlements under benefit plans
(including stock option plans), in each case to be paid or provided to the Executive under this Agreement or otherwise and accrued through the Date of Termination (as defined in Section 10(h) hereof) (collectively, the “Accrued
Obligations”), (ii) to the extent applicable, an amount equal to the pro rata bonus (the 

  
 2 

 
“Pro Rata Bonus”) determined by comparing the Company’s actual performance measures applicable to the Bonus for the fiscal year in which the Date of Termination occurs (the
“Performance Measures”) for the period beginning on the first day of the fiscal year during which the Date of Termination occurs and ending on the last day of the month in which the Date of Termination occurs, (such period, the “Bonus
Measuring Period”) with the aggregate budgeted Performance Measures as reflected in the monthly budgets prepared by the Company and accepted by the Board with respect to such period, and (iii) any other death benefits arrangements
available to senior executive officers of the Company generally, as in effect on the Date of Termination. The Pro Rata Bonus shall be in an amount equal to the product of (I) a fraction, the numerator of which equals the number of months in the
Bonus Measuring Period and the denominator of which equals twelve and (II) the bonus set forth in the Bonus Plan for the fiscal year in which the Date of Termination occurs, treating the Bonus Measuring Period as if it was the full fiscal year for
purposes of determining the Executive’s bonus percentage. The payments required to be paid pursuant to this paragraph 10(b) shall be paid to the Executive’s spouse or heirs no later than ten (10) days following the Date of
Termination; provided, however, that any Pro Rata Bonus shall be paid to the Executive’s spouse or heirs no later than five (5) days following the determination of the amount of such payments, if any, and provided, further, that any
benefits payable pursuant to Subsection (iii) shall be payable in accordance with the Company’s normal practices as are in effect at that time. Additionally, in the event the Executive’s employment is terminated pursuant to this
Section 10(b), all of the Executive’s options to purchase shares of capital stock of the Company which are unvested as of the Date of Termination but otherwise scheduled to vest on the first vesting date scheduled to occur following the
Date of Termination, shall immediately vest and become exercisable on the Date of Termination and all remaining unvested options shall terminate as of the Date of Termination. In the event the Executive’s employment is terminated pursuant to
this Section 10(b), all of the Executive’s options to purchase capital stock of the Company which are vested as of the Date of Termination or become vested pursuant to the immediately preceding sentence may be exercised by the
Executive’s spouse or heirs within the earlier of (i) the tenth anniversary of the date the options were granted or (ii) one (1) year following the Date of Termination and shall then terminate, and the Executive’s spouse or
heirs shall be permitted to exercise such options on a net basis (e.g., by satisfying the exercise price and withholding tax obligations having withheld a number of option shares that have a fair market value equal to such obligations). 

(c) Disability. The Executive’s employment pursuant to this Agreement may be terminated by written notice to
the Executive by the Company or to the Company by the Executive in the event that (i) the Executive becomes unable to perform his duties as set forth in Section 3 by reason of physical or mental illness or accident for any six
(6) consecutive month period or (ii) the Company receives written opinions from both a physician for the Company and a physician for the Executive that the Executive will be so disabled. In the event the Executive’s employment is
terminated pursuant to this Section 10(c), the Executive shall be entitled to receive (A) the Accrued Obligations, (B) to the extent applicable, an amount equal to the Pro Rata Bonus, and (C) any other Disability benefits
arrangements available to senior executive officers of the Company generally, as in effect on the Date of Termination (as defined in Section 10(h) hereof). All of the payments required to be paid pursuant to this Section 10(c) shall be
paid to the Executive no later than ten (10) days following the Date of Termination; provided, however, that any Pro Rata Bonus shall be paid to the Executive no later than five (5) days following the determination of the amount of such
payments, if any, and provided, further, that any benefits payable pursuant to Subsection (C) shall be payable in accordance with the Company’s normal practices, as are in effect at that time. Additionally, in the event the
Executive’s employment is terminated pursuant to this Section 10(c), all of the Executive’s options to purchase shares of capital stock of the Company which are unvested as of the Date of Termination but otherwise scheduled to vest on
the first vesting date scheduled to occur following the Date of Termination, shall immediately vest and become exercisable on the Date of Termination and all remaining unvested options shall terminate as of the Date of Termination. In the event the
Executive’s employment is terminated pursuant to this Section 10(c), all of the Executive’s options to purchase capital stock of the 

  
 3 

 
Company which are vested as of the Date of Termination or become vested pursuant to the immediately preceding sentence may be exercised by the Executive within the earlier of (i) the tenth
anniversary of the date the options were granted or (ii) one (1) year following the Date of Termination and shall then terminate, and the Executive (or the Executive’s spouse or heirs) shall be permitted to exercise such options on a
net basis (e.g., by satisfying the exercise price and withholding tax obligations having withheld a number of option shares that have a fair market value equal to such obligations). 

(d) By the Company for Cause. The Executive’s employment pursuant to this Agreement may be terminated by
written notice to the Executive (“Notice of Termination”) upon the occurrence of any of the following events (each of which shall constitute “Cause” for termination): (i) the Executive commits any act of gross negligence,
fraud or willful misconduct causing material harm to the Company, (ii) the conviction of the Executive of a felony that would reasonably be expected by the Company to adversely affect the Company or its reputation, (iii) the Executive
intentionally obtains material personal gain, profit or enrichment at the expense of the Company or from any transaction in which the Executive has an interest which is adverse to the interest of the Company, unless the Executive shall have obtained
the prior written consent of the Board, or (iv) any material breach of the Executive of this Agreement, including, without limitation, a material breach of Section 14 hereof, which breach remains uncorrected for a period of fifteen
(15) days after receipt by the Executive of written notice from the Company setting forth the breach. In the event the Executive’s employment is terminated pursuant to this Section 10(d), the Executive shall be entitled to receive all
the Accrued Obligations and no more. 
 (e) By the Company Without Cause. The Executive’s employment
pursuant to this Agreement may be terminated by the Company at any time without Cause by delivery of a Notice of Termination to the Executive. In the event that the Executive’s employment is terminated pursuant to this Section 10(e), the
Executive shall be entitled to receive (i) the Accrued Obligations, (ii) an amount equal to (a) one hundred fifty percent (150%) of the Executive’s Base Salary and (b) one hundred fifty percent (150%) of the annual
Bonus Target, in each case at the rate in effect immediately prior to the Date of Termination (without regard to any reductions of such rate, or failure to increase such rate, in breach of this Agreement), (iii) to the extent applicable, an
amount equal to the Pro Rata Bonus, and (iv) a lump sum payment equal to the then present value of all major medical, disability and life insurance coverage to be provided pursuant to Section 9 above through the date eighteen
(18) months after the Date of Termination, provided that under such circumstances the Executive shall make all COBRA premium payments on his own behalf. The sum of the amounts described in clauses (ii) and (iv) above are hereafter
referred to as the “Section 10(e) Severance Amount.” The amounts described in clause (i) shall be paid to the Executive no later than ten (10) days following the Date of Termination; any amount payable under clause
(iii) shall be paid to the Executive no later than five (5) days following the determination of the amount of such payment, if any. All of the Section 10(e) Severance Amount shall be paid to the Executive no later than ten
(10) days following the later of (x) the Date of Termination and (y) the execution of an agreement by the Executive, in form and substance reasonably satisfactory to the Company, providing for (I) a full release by the Executive
of the Company, its officers, directors, representatives and affiliates from all liabilities, obligations or claims, other than those obligations specifically provided in this Section 10(e) and rights to indemnification, (II) an affirmation of
the Executive’s obligations pursuant to Section 14 hereof and (III) an agreement by the Executive to immediately repay to the Company one hundred percent (100%) of the Section 10(e) Severance Amount upon any breach of such
agreement. Additionally, in the event that the Executive’s employment is terminated pursuant to this Section 10(e), all of the Executive’s options to purchase shares of capital stock of the Company which are unvested as of the Date of
Termination but otherwise scheduled to vest on the first vesting date scheduled to occur following the Date of Termination, shall immediately vest and become exercisable on the Date of Termination and all remaining unvested options shall terminate
as of the Date of Termination. In the event the Executive’s employment is terminated pursuant to this Section 10(e), all of the Executive’s options to purchase capital stock of the Company that

  
 4 

 
are vested as of the Date of Termination or become vested pursuant to the immediately preceding sentence may be exercised by the Executive within the earlier of (i) the tenth anniversary of
the date the options were granted or (ii) one (1) year following the Date of Termination and shall then terminate, and the Executive (or the Executive’s spouse or heirs) shall be permitted to exercise such options on a net basis
(e.g., by satisfying the exercise price and withholding tax obligations having withheld a number of option shares that have a fair market value equal to such obligations). 

(f) By the Executive for Good Reason. The Executive’s employment pursuant to this Agreement may be terminated
by the Executive by written notice of his resignation (“Notice of Resignation”) delivered within twelve (12) months after the occurrence of any of the following events (each of which shall constitute “Good Reason” for
resignation): (i) the removal of the Executive from the position of General Counsel of the Company, (ii) any material reduction by the Company of the Executive’s duties or responsibilities or the assignment to the Executive of duties
materially inconsistent with such position, which breach remains uncorrected for a period of thirty (30) days after receipt by the Company of written notice from the Executive or (iii) any breach by the Company of this Agreement (including
the provisions of Section 3), which breach remains uncorrected for a period of thirty (30) days after receipt by the Company of written notice from the Executive. In the event that the Executive resigns for Good Reason pursuant to this
Section 10(f), the Executive shall be entitled to receive, (A) the Accrued Obligations, (B) an amount equal to (i) one hundred fifty percent (150%) of the Executive’s Base Salary and (ii) one hundred fifty percent
(150%) of the Bonus Target, in each case at the rate in effect immediately prior to the Date of Termination (without regard to any reductions of such rate, or failure to increase such rate, in breach of this Agreement), (C) to the extent
applicable, an amount equal to the Pro Rata Bonus, and (D) a lump sum payment equal to the then present value of all major medical, disability and life insurance coverage to be provided pursuant to Section 9 above through the date eighteen
(18) months after the Date of Termination, provided that under such circumstances the Executive shall make all COBRA premium payments on his own behalf. The sum of the amounts described in clauses (B) and (D) above are hereafter
referred to as the “Section 10(f) Severance Amount.” All of the amounts described in clause (A) shall be paid to the Executive no later than ten (10) days following the Date of Termination; any amount payable under clause
(C) shall be paid to the Executive no later than five (5) days following the determination of the amount of such payment, if any. All of the Section 10(f) Severance Amount shall be paid to the Executive no later than ten
(10) days following the later of (x) the Date of Termination and (y) the execution of an agreement by the Executive, in form and substance reasonably satisfactory to the Company, providing for (I) a full release by the Executive
of the Company, its officers, directors, representatives and affiliates from all liabilities, obligations or claims, other than those obligations specifically provided in this Section 10(f) and rights to indemnification, (II) an affirmation of
the Executive’s obligations pursuant to Section 14 hereof and (III) an agreement by the Executive to immediately repay to the Company one hundred percent (100%) of the Section 10(f) Severance Amount upon any breach of such
agreement. Additionally, in the event that the Executive’s employment is terminated pursuant to this Section 10(f), all of the Executive’s options to purchase shares of capital stock of the Company which are unvested as of the Date of
Termination but otherwise scheduled to vest on the first vesting date scheduled to occur following the Date of Termination, shall immediately vest and become exercisable on the Date of Termination and all remaining unvested options shall terminate
as of the Date of Termination. In the event the Executive’s employment is terminated pursuant to this Section 10(f), all of the Executive’s options to purchase capital stock of the Company that are vested as of the applicable Date of
Termination or become vested pursuant to the immediately preceding sentence may be exercised by the Executive within the earlier of (i) the tenth anniversary of the date the options were granted or (ii) one (1) year following the Date
of Termination and shall then terminate, and the Executive (or the Executive’s spouse or heirs) shall be permitted to exercise such options on a net basis (e.g., by satisfying the exercise price and withholding tax obligations having withheld a
number of option shares that have a fair market value equal to such obligations). 

  
 5 

 (g) By the Executive Without Good Reason or Executive’s Failure to
Extend Term. The Executive’s employment pursuant to this Agreement may be terminated by the Executive at any time by delivery of a Notice of Resignation to the Company or by the Executive providing notice to the Company of his intent not to
extend the Term for any additional period as provided in Section 2(b). In the event that the Executive’s employment is terminated pursuant to this Section 10(g), the Executive shall receive the Accrued Obligations and no more.

 (h) Date of Termination. The Executive’s Date of Termination shall be (i) if the
Executive’s employment is terminated pursuant to Section 10(b), the date of his death, (ii) if the Executive’s employment is terminated pursuant to Section 10(c), the last day of the six-month period referred to in
Section 10(c)(i) or the date of delivery of the last physician’s opinion referred to in Section 10(c)(ii), as the case may be, (iii) if the Executive’s employment is terminated pursuant to Section 10(d), 10(e) or 10(f),
the date on which a Notice of Termination is given or such other date as specified in such Notice, (iv) if the Executive’s employment is terminated pursuant to Section 10(g) (other than as a result of Executive’s failure to
extend the Term), one hundred twenty (120) days after the date the Notice of Resignation is given or such shorter period as may be determined by the Company and (v) if the Company or Executive provides notice of its or his intent not to
extend the Term for any additional period as provided in Section 2(b), the expiration of the Term. 
 (i)
Company’s Failure to Extend Term. In the event the Company provides notice of its intent not to extend the Term for any additional period as provided in Section 2(b) and the Executive is not then in violation of Section 14
hereof, the Executive shall be entitled to receive (i) the Accrued Obligations; (ii) an amount equal to (a) one hundred percent (100%) of the Executive’s Base Salary and (b) the annual Bonus Target, in each case at the
rate in effect immediately prior to the provision of such notice (without regard to any reductions of such rate, or failure to increase such rate, in breach of this Agreement); (iii) to the extent applicable, an amount equal to the Pro Rata
Bonus, and (iv) a lump sum payment equal to the then present value of all major medical, disability and life insurance coverage to be provided pursuant to Section 9 above through the date twelve (12) months after the Date of
Termination, provided that under such circumstances the Executive shall make all COBRA premium payments on his own behalf. The sum of the amounts described in clauses (ii) and (iv) above are hereafter referred to as the “Section 10(i)
Severance Amount.” The amounts described in clause (i) shall be paid to the Executive no later than ten (10) days following the Date of Termination; any amount payable under clause (iii) shall be paid to the Executive no later
than five (5) days following the determination of the amount of such payment, if any. All of the Section 10(i) Severance Amount shall be paid to the Executive no later than ten (10) days following the later of (x) the Date of
Termination and (y) the execution of an agreement by the Executive, in form and substance reasonably satisfactory to the Company, providing for (I) a full release by the Executive of the Company, its officers, directors, representatives
and affiliates from all liabilities, obligations or claims, other than those obligations specifically provided in this Section 10(i) and rights to indemnification, (II) an affirmation of the Executive’s obligations pursuant to
Section 14 hereof and (III) an agreement by the Executive to immediately repay to the Company one hundred percent (100%) of the Section 10(i) Severance Amount upon any breach of such agreement. 

(j) Notwithstanding any provision herein to the contrary, the provisions of this Section 10(j) shall apply to the
payment of the Section 10(e) Severance Amount, the Section 10(f) Severance Amount and the Section 10(i) Severance Amount (the “Release Payments”). The Release Payments shall be made only if Executive shall have executed, on
or prior to the Release Expiration Date (as defined below), the release, affirmation and agreement described in Sections 10(e), (f) or (i), as applicable, hereof (the “Release”) and any waiting periods contained in the Release shall
have expired. In any instance where the execution of a Release is required, the Company shall deliver the Release in form and substance reasonably satisfactory to the Company to Executive within five (5) business

  
 6 

 
days following the date on which Notice of Termination (or Notice of Resignation or notice of the Company’s intent not to extend the Term for an additional period, as the case may be and for
purposes of this Section 10(j), collectively “Notice of Termination”) is given. If Executive fails to execute the Release on or prior to the Release Expiration Date or timely revokes Executive’s acceptance of the Release
thereafter, Executive shall not be entitled to any Release Payments. The Release Payments shall be made immediately upon the expiration of any waiting periods contained in the Release, or if no waiting periods are applicable, within two business
days following Executive’s execution and delivery of the Release to the Company; provided, however, notwithstanding anything herein to the contrary, in any case where the date the Notice of Termination and the Release Expiration Date fall in
two separate taxable years, any Release Payments that are treated as deferred compensation for purposes of Section 409A of the Code shall be made in the later taxable year. For purposes of this Section 10(j), the “Release Expiration
Date” shall mean the later of (i) Executive’s Date of Termination, and (ii) the date that is twenty-one (21) days following the date on which the Company timely delivers a Release to the Executive for Executive’s
execution, or in the event that a termination of employment is “in connection with an exit incentive or other employment termination program” (as such phrase is defined in the Age Discrimination in Employment Act of 1967), the date that is
forty-five (45) days following such delivery date. 
 (k) Other Section 409A Matters.

 (i) In any case that a Pro Rata Bonus must be determined, the Company shall make such determination by the
end of the month following the month in which the Executive’s Date of Termination occurs. 
 (ii) It is
intended that (A) each installment of the payments provided under this Agreement is a separate “payment” for purposes of Section 409A of the Internal Revenue Code (the “Code”) and (B) that the payments satisfy, to
the greatest extent possible, the exemptions from the application of Section 409A of the Code provided under Treasury Regulations 1.409A- 1(b)(4), 1.409A-1(b)(9)(iii), and 1.409A-1(b)(9)(v). 

(iii) Notwithstanding anything to the contrary in this Agreement, if the Company determines (A) that on the date
the Executive’s employment with the Company terminates or at such other time that the Company determines to be relevant, the Executive is a “specified employee” (as such term is defined under Treasury Regulation 1.409A-1(i)(1)) of the
Company and (B) that any payments to be provided to the Executive pursuant to this Agreement are or may become subject to the additional tax under Section 409A(a)(1)(B) of the Code or any other taxes or penalties imposed under
Section 409A of the Code if provided at the time otherwise required under this Agreement then such payments shall be delayed until the date that is six (6) months after the date of the Executive’s “separation from service”
(as such term is defined under Treasury Regulation 1.409A-1(h)) with the Company, or, if earlier, the date of the Executive’s death. Any payments delayed pursuant to this Section 10(k)(iii) shall be made in a lump sum on the first day
following the end of the six (6) month period described above, or, if earlier, upon Executive’s death. 
 (iv) To the extent that any reimbursement, fringe benefit or other, similar plan or arrangement in which the Executive participates during the term of Executive’s employment under this Agreement or
thereafter provides for a “deferral of compensation” within the meaning of Section 409A of the Code, subject to any shorter time periods provided herein or the applicable plans or arrangements, any reimbursement or payment of an
expense under such plan or arrangement must be made on or before the last day of the calendar year following the calendar year in which the expense was incurred. 

11. Excise Tax. The parties hereto agree to reasonably cooperate with each other to minimize any taxes that may be
imposed under Section 4999 of the Code which may include, at the Executive’s election, the Executive waiving a portion of his payment unless approved by the shareholders. 

  
 7 

 12. Representations. 

(a) The Company represents and warrants that this Agreement has been authorized by all necessary corporate action of the
Company and is a valid and binding agreement of the Company enforceable against it in accordance with its terms. 
 (b) The Executive represents and warrants that he is not a party to any agreement or instrument, which would prevent him from entering into or performing his duties in any way under this Agreement, and
that this is a valid and binding agreement of the Executive enforceable against him in accordance with its terms. 
 13. Assignment; Binding Agreement. This Agreement is a personal contract and the rights and interests of the Executive hereunder may not be sold, transferred, assigned, pledged, encumbered, or
hypothecated by him, except as otherwise expressly permitted by the provisions of this Agreement. This Agreement shall inure to the benefit of and be enforceable by the Executive and his personal or legal representatives, executors, administrators,
successors, heirs, distributees, devisees and legatees. If the Executive should die while any amount would still be payable to him hereunder had the Executive continued to live, all such amounts, unless otherwise provided herein, shall be paid in
accordance with the terms of this Agreement to his devisee, legatee or other designee or, if there is no such designee, to his estate. 
 14. Confidentiality; Non-Competition; Ownership of Works. 

(a) The Executive acknowledges that: (i) the Business is intensely competitive and that the Executive’s
employment by the Company will require that the Executive have access to and knowledge of confidential information of the Company relating to the Business, including, but not limited to, the identity of the Company’s employees, physicians,
payors or suppliers, the kinds of services provided by the Company, the manner in which such services are performed or offered to be performed, the service needs of actual or prospective patients, physicians or payors, pricing information and other
contractual terms, information concerning the creation, acquisition or disposition of products and services, creative ideas and concepts, including clinical and financial systems, compliance programs and physician relation and retention programs,
computer software applications and other programs, research data, personnel information and other trade secrets, in each case other than as and to the extent such information is generally known or publicly available through no violation of this
Section 14 by the Executive or such information is readily discernible (the “Confidential Information”); (ii) the disclosure of any such Confidential Information may place the Company at a competitive disadvantage and may do
damage, monetary or otherwise, to the Company’s business; and (iii) the engaging by the Executive in any of the activities prohibited by this Section 14 may constitute improper appropriation and/or use of such Confidential
Information. The Executive expressly acknowledges the trade secret status of the Confidential Information and that the Confidential Information constitutes a protectable business interest in the Company. Accordingly, the Company and the Executive
agree as follows: 
 (b) For purposes of this Section 14, the Company shall be construed to include the
Company and its parents and subsidiaries engaged in the Business, including any divisions managed by the Executive. 

  
 8 

 (c) During the Executive’s employment with the Company, and at all
times after the termination of the Executive’s employment by expiration of the Term or otherwise, the Executive shall not, directly or indirectly, whether individually, as a director, stockholder, owner, partner, employee, principal or agent of
any business, or in any other capacity, make known, disclose, furnish, make available or utilize any of the Confidential Information, other than in the proper performance of the duties contemplated herein, or as expressly permitted herein, or as
required by a court of competent jurisdiction or other administrative or legislative body, provided that the Executive shall promptly notify the Company so that the Company may seek a protective order or other appropriate remedy. The Executive
agrees to return all documents or other materials containing Confidential Information, including all photocopies, extracts and summaries thereof, and any such information stored electronically on tapes, computer disks or in any other manner to the
Company at any time upon request by the Company and immediately upon the termination of his employment for any reason. 
 (d) For a period of eighteen (18) months following the Executive’s Date of Termination for any reason other than the Company’s failure to extend the Term, in which case such period shall be
reduced to twelve (12) months, the Executive shall not engage in Competition, as defined below, with the Company or its subsidiaries within twenty-five (25) miles of the location of any hospital managed by the Company (or other facility
managed by the Company from which in excess of five percent (5%) of the Company’s annual revenues are derived) at the time of, or within six (6) months prior to, the Executive’s Date of Termination or the expiration of the Term,
as applicable (each, an “Affected Facility”), or in which, during the three (3) month period immediately prior to the Executive’s Date of Termination or the expiration of the Term (as applicable), the Company had made substantial
plans with the intention of establishing operations in such locality or region. For purposes of this Agreement, “Competition” by the Executive shall mean the Executive’s engaging in any activities relating to, or otherwise directly or
indirectly being employed by or acting as a consultant or lender to, or being a director, officer, employee, principal, agent, stockholder, member, owner or partner of, or permitting his name to be used in connection with the activities of any
entity engaged in significant activities relating to, the Business. Notwithstanding the foregoing, it shall not be a violation of this paragraph for the Executive to (ii) be a consultant to, or a director, officer, employee, or agent of, any
entity engaged in the Business which has hospitals or other facilities within twenty-five (25) miles of any Affected Facility, so long as the Executive does not provide any services or advice to, or have any management supervision of, or
responsibility for, any hospital or other facility located within twenty-five (25) miles of any Affected Facility; or (ii) become the registered or beneficial owner of up to five percent (5%) of any class of the capital stock of any
one or more competing corporations registered under the Securities Exchange Act of 1934, as amended, provided that the Executive does not actively participate in the business of such corporation until such time as this covenant expires. In the event
that the Executive breaches the restrictions set forth in Section 14(d) following a termination pursuant to Section 10(e), 10(f) or 10(i), the Executive shall pay the Company “Liquidated Damages” (as hereinafter defined) within
ten (10) days following any such breach. If Executive’s employment is terminated pursuant to Section 10(e), 10(f) or 10(i) and the Executive has repaid the full amount of the Liquidated Damages as provided pursuant to the immediately
preceding sentence, the Company shall not be entitled to any remedy, including, without limitation, additional damages or injunctive relief, upon Executive’s breach of Section 14(d). “Liquidated Damages” shall mean the
Section 10(e) Severance Amount, Section 10(f) Severance Amount or Section 10(i) Severance Amount received by the Executive, as the case may be. 
 (e) For a period of eighteen (18) months following the Executive’s Date of Termination for any reason other than the Company’s failure to extend the Term, in which case such period shall be
reduced to twelve (12) months, the Executive agrees that he will not, directly or indirectly, for his benefit or for the benefit of any other person, firm or entity, do any of the following: 

(i) solicit from any physician or physician group doing business with the Company as of the Executive’s
termination, business of the same or of a similar nature to the business of the Company with such physician or physician group; 

  
 9 

 (ii) solicit from any known potential physician group business of the same
or of a similar nature to that which has been the subject of a known written or oral bid, offer or proposal by the Company, or of substantial preparation with a view to making such a bid, proposal or offer, within six (6) months prior to the
Executive’s termination; or 
 (iii) recruit or solicit the employment or services of any person who was
employed by the Company upon termination of the Executive’s employment and is employed by the Company at the time of such recruitment or solicitation. 
 (f) The Executive will make full and prompt disclosure to the Company of all inventions, improvements, formulas, data, programs, processes, ideas, concepts, discoveries, methods, developments, software,
and works of authorship, whether or not copyrightable, trademarkable or patentable, which relate to the actual or anticipated business, activities or research of the Company and either (i) are created, made, conceived or reduced to practice by
the Executive, either alone, under his direction or jointly with others during the period of his employment with the Company, (ii) result from or are suggested by work performed by the executive for the Company or (iii) result, to any
extent, from use of the Company’s premises or property (all of which are collectively referred to in this Agreement as “Works”). All Works shall be the sole property of the Company, and, to the extent that the Company is not already
considered the owner thereof as a matter of law, the Executive hereby assigns to the Company, without further compensation, all his right, title and interest in and to such Works and any and all related intellectual property rights (including, but
not limited to, patents, patent applications, copyrights, copyright applications, and trademarks) in the United States and elsewhere. 
 (g) The Executive acknowledges that the services to be rendered by him to the Company are of a special and unique character, which gives this Agreement a peculiar value to the Company, the loss of which
may not be reasonably or adequately compensated for by damages in an action at law, and that a breach or threatened breach by him of any of the provisions contained in this Section 14 may cause the Company irreparable injury. The Executive
therefore agrees that the Company may be entitled, in addition to any other right or remedy, to a temporary, preliminary and permanent injunction, without the necessity of proving the inadequacy of monetary damages or the posting of any bond or
security, enjoining or restraining the Executive from any such violation or threatened violations. 
 (h) If any
one or more of the provisions contained in this Agreement shall be held to be excessively broad as to duration, activity or subject or unenforceable under applicable law, including professional ethics standards applicable to attorneys, such
provisions shall be construed by limiting and reducing them so as to be enforceable to the fullest extent permitted by law. 
 15. Entire Agreement. This Agreement contains all the understandings between the parties hereto pertaining to the matters referred to herein, and supersedes any other undertakings and agreements,
whether oral or in writing, previously entered into by them with respect thereto. The Executive represents that, in executing this Agreement, he does not rely and has not relied upon any representation or statement not set forth herein made by the
Company with regard to the subject matter or effect of this Agreement or otherwise. 
 16. Amendment or
Modification Waiver. No provision of this Agreement may be amended or waived, unless such amendment or waiver is agreed to in writing, signed by the Executive and by a duly authorized officer of the Company. No waiver by any party hereto of any
breach by another party hereto of any condition or provision of this Agreement to be performed by such other party shall be deemed a waiver of a similar or dissimilar condition or provision at the same time, any prior time or any subsequent time.

  
 10 

 17. Expenses. Each party shall bear its own expenses in connection
with the negotiation, execution, delivery and performance of this Agreement and the resolution of any disputes hereunder. 
 18. Notices. Any notice to be given hereunder shall be in writing and shall be deemed given when delivered personally, sent by courier or facsimile or registered or certified mail, postage prepaid,
return receipt requested, addressed to the party concerned at the address indicated below or to such other address as such party may subsequently give notice hereunder in writing: 

 

			
	 To the Executive at the address
	  	 Frank A. Cayle

	on file with the Company:	  	 505 Waxwood Drive

		  	 Brentwood, TN 37027

		
	To the Company at:	  	 IASIS Healthcare Corporation

		  	Dover Centre
		  	117 Seaboard Lane, Building E
		  	Franklin, TN 37067
		  	Attention: Chief Executive Officer
		
	With copies to IASIS Investment LLC at:	  	 IASIS Investment LLC

		  	301 Commerce Street, Suite 3300
		  	Fort Worth, TX 76102
		  	Attention: Secretary
		
		  	and
		
		  	Cleary, Gottlieb, Steen & Hamilton
		  	One Liberty Plaza
		  	New York, NY 10006
		  	Attention: Robert J. Raymond

 Any notice delivered personally or by courier under this Section 18 shall be deemed given on the
date delivered and any notice sent by facsimile or registered or certified mail, postage prepaid, return receipt requested, shall be deemed given on the date transmitted by facsimile or three business days after it is mailed. 

19. Severability. If any provision of this Agreement or the application of any such provision to any party or
circumstances shall be determined by any court of competent jurisdiction to be invalid and unenforceable to any extent, the remainder of this Agreement or the application of such provision to such person or circumstances other than those to which it
is so determined to be invalid and unenforceable, shall not be affected thereby, and each provision hereof shall be validated and shall be enforced to the fullest extent permitted by law. 

20. Survivorship. The respective rights and obligations of the parties hereunder shall survive any termination of
this Agreement to the extent necessary to the intended preservation of such rights and obligations. 
 21.
Governing Law: Venue. This Agreement will be governed by and construed in accordance with the laws of the State of Delaware, without regard to the principles of conflicts of law thereof. 

  
 11 

 22. Headings. All descriptive headings of sections and paragraphs in
this Agreement are intended solely for convenience, and no provision of this Agreement is to be construed by reference to the heading of any section or paragraph. 

23. Withholding. All payments to the Executive under this Agreement shall be reduced by all applicable withholding
required by federal, state or local law. 
 24. Counterparts. This Agreement may be executed in
counterparts, each of which shall be deemed an original, but all of which together shall constitute one and the same instrument. 

[SIGNATURE PAGE FOLLOWS] 

  
 12 

 IN WITNESS WHEREOF, the parties hereto have executed this Employment
Agreement as of the date first written above. 
  

			
	IASIS HEALTHCARE CORPORATION
		
	By:	 	/s/ W. Carl Whitmer
		 	Name: W. Carl Whitmer
		 	Title: Chief Executive Officer
		
		 	/s/ Frank A. Coyle
		 	Frank A. Coyle

  
 13First Amendment to the Program Services Agreement

 Exhibit 10.6.7 
 FIRST AMENDMENT TO THE 
 PROGRAM SERVICES AGREEMENT 

THIS AMENDMENT is effective as of August 22, 2011, by and between ING Life Insurance and Annuity Company (“ING”)
and the ABA Retirement Funds (the “ABA RF”). 
 WHEREAS, ING and the ABA RF entered into a Program Services
Agreement, effective as of May 1, 2009 (the “Agreement”); 
 WHEREAS, the parties now desire to amend the
Agreement to provide that, effective August 22, 2011, the provider of the Self-Managed Option (as defined in the Agreement) shall be engaged by ABA RF, in its sole and absolute discretion. 

NOW, THEREFORE, pursuant to Section 13.06 of the Agreement, the Agreement is hereby amended as follows: 

1. The following new Sections 1.12, 1.13 and 1.14 are added to Article 1 of the Agreement immediately after Section 1.11 appearing
therein, and the remaining Section thereof and cross-references thereto are appropriately renumbered: 
  

	 	1.12.	“Brokerage Interface Procedures” means the procedures established between ING and the Brokerage Services Provider pursuant to Section 9.01.

  

	 	1.13.	“Brokerage Services Agreement” means the agreement between ABA RF and the Brokerage Services Provider for the provision of brokerage services for the
Self-Managed Option. 

  

	 	1.14.	“Brokerage Services Provider” means TD Ameritrade, Inc. or such other entity as the ABA RF shall engage to provide brokerage services for the
Self-Managed Option. 

  

	 	2.	Section 9.01(b) is amended in its entirety to read as follows: 

 9.01(b) Self-Managed Option. Within 30 days after the date on which it is notified that the ABA RF has engaged a Brokerage Services Provider, ING shall enter into the Brokerage Interface Procedures
agreement with such Brokerage Services Provider. The Brokerage Interface Procedures agreement shall contain such provisions as the parties shall deem necessary or appropriate to maintain the Self-Managed Option under the Program, to provide access
thereto pursuant to the facilities provided by ING pursuant to Sections 3.03, 3.04, 3.05, 3.06 and 3.07 to include relevant information in the Program’s Records and Data and such other items as shall be necessary or appropriate for ING to carry
out its obligations under the Agreement with respect to the Self-Managed Option. ABA RF shall not be a party to the Brokerage Interface Procedures agreement, but such agreement shall name ABA RF as a third-party

 
beneficiary thereof with a right to enforce the Brokerage Interface Procedures agreement on behalf of the Program. In no event shall the Brokerage Interface Procedures agreement be executed or
amended unless the form thereof has been approved in writing by ABA RF. Notwithstanding the foregoing, in lieu of entering into a Program Interface Procedures agreement, ING may, together with the Brokerage Services Provider, represent and warrant
to the ABA RF that a Program Interface Procedures agreement is not necessary because they have already in place the necessary agreements or understanding, and ING shall covenant in writing to the ABA RF that no dispute between ING and the Brokerage
Services Provider shall result in any interruption of the services required hereunder to the extent initiated by ING. 
 IN
WITNESS WHEREOF, the undersigned have executed this First Amendment to the Program Services Agreement by their duly authorized officers as the date first written above. 

 

							
	ING Life Insurance and Annuity Company	 	ABA Retirement Funds
				
	By:	 	/s/ Ralph R. Ferraro	 	By:	 	/s/ M. Catherine Richardson
	Name:	 	Ralph R. Ferraro	 	Name:	 	M. Catherine Richardson
	Title:	 	Senior Vice President	 	Title:	 	President

  

			
	ING Institutional Plan Services, LLC
		
	By:	 	/s/ Beth Halberstadt
	Name:	 	Beth Halberstadt
	 Title:
	 	Senior Vice President

  
 2 

 REPRESENTATION & WARRANTY 
 Pursuant to Section 9.01(b) of the Program Services Agreement, ING Life Insurance and Annuity Company (“ING”) hereby represents and warrants to the ABA Retirement Funds (“ABA RF”)
that a Brokerage Interface Procedures agreement between ING and the Brokerage Services Provider is not necessary because ING or its affiliates already have in place the necessary agreements or understanding with the Brokerage Services Provider to
maintain the Self-Managed Option under the Program. 
  

			
	ING Life Insurance and Annuity Company
		
	By:	 	 /s/ Ralph R. Ferraro

	Name:	 	 Ralph R. Ferraro

	Title:	 	 Senior Vice President

		
	Date:	 	December 19, 2011

  
 3

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00197-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00197-of-00352.parquet"}]]